Brellium
+81%
est. 2Y upside i
Rank
#610
Sector
Healthcare Technology
Est. Liquidity
~4Y
Data Quality
Data: MediumBrellium offers a high-upside, high-risk private equity opportunity: $6.4M ARR growing ~129% YoY, a $54M Series A valuation, and a projected $21.7M ARR in 24 months.
Last updated: August 3, 2026
Projected revenue of $21.7M at 7.5x forward revenue yields a $162M exit (3.0x entry), net of 20% dilution gives +181%. Upside expands if an IPO window opens or Brellium cements AI compliance category leadership.
Exit at 5x forward revenue gives $108M (2.0x entry), net of 20% dilution gives +81%. Multiple converges toward public comps (WK/VEEV/HCAT) despite continued strong growth.
Compression to 2x forward revenue yields $43M exit, below the current $54M valuation; net of dilution, -40%. Exit value remains above the $28M liquidation preference, so common stock recovers a little value, but shareholders are underwater.
Preference Stack Risk
severeFunding Intensity
52%Total funding of $28M equals 52% of the $54M entry valuation, so preferred holders take $28M off the top in any liquidation.
Dilution Risk
highLikely follow-on financing within 24 months; assumed 20% dilution for common/option holders.
Secondary Liquidity
noneNo secondary market is indicated from the data; shares are likely illiquid until a liquidity event.
Customer Success — 4 roles
- Customer Success Associate · New York City
- Customer Success Manager · New York City
- Implementation Manager · New York City
- +1 more →
Engineering — 3 roles
- Senior Software Engineer · New York City
- Software Engineer · New York City
- Software Engineer - AI · New York City
People — 2 roles
- Executive Assistant to the CEO · New York City
- Senior Recruiter · New York City
Sales — 2 roles
- Account Executive (NYC) · New York City
- Business Development Representative · New York City
Finance — 1 role
- Controller · New York City
Product — 1 role
- Product Manager · New York City
Last updated: February 22, 2026
Questions to Ask at the Interview
Strategic questions based on Brellium's data — designed to show you've done your homework.
- 1
“How will Brellium respond if Epic/Cerner bundle AI compliance features into core EHR workflows?”
- 2
“What is net revenue retention, and how does the reimbursement guarantee impact gross margin as chart volume scales?”
- 3
“Can you share the latest 409A valuation and whether there have been any secondary tender offers or liquidity windows?”
Community
Valuation Sentiment
Our model estimates +81% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.